CABAZITAXEL-TEVA cabazitaxel 60 mg/6 mL concentrated injection vial

Land: Australien

Språk: engelska

Källa: Department of Health (Therapeutic Goods Administration)

Aktiva substanser:

cabazitaxel ethyl acetate solvate, Quantity: 66.32 mg (Equivalent: cabazitaxel, Qty 60 mg)

Tillgänglig från:

Teva Pharma Australia Pty Ltd

Läkemedelsform:

Injection, concentrated

Sammansättning:

Excipient Ingredients: macrogol 400; citric acid; polysorbate 80; ethanol absolute

Administreringssätt:

Intravenous Infusion

Enheter i paketet:

1 vial

Receptbelagda typ:

(S4) Prescription Only Medicine

Terapeutiska indikationer:

Cabazitaxel-Teva in combination with prednisone or prednisolone is indicated for the treatment of patients with metastatic castration resistant prostate cancer previously treated with a docetaxel containing regimen.

Produktsammanfattning:

Visual Identification: Cabazitaxel-Teva is presented as a 60 mg/6 mL sterile, clear, oily, light yellow solution in a single use vial, practically free from visible particles.; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius; Container Closure: Child resistant closure

Bemyndigande status:

Registered

Tillstånd datum:

2020-09-16